AnnSofie Sternas - Karolinska Development Vice President IPR

KDEV Stock  SEK 1.52  0.02  1.30%   

President

Ms. AnnSofie Sternas was Vice President IPR at Karolinska Development AB since June 2012. She is European Patent Attorney and holds MS in Chemical Engineering. AnnSofie Sternas has almost 20 years of IP experience from large pharmaceutical companies and has held senior IPR positions within Astra and AstraZeneca. During many years AnnSofie was heavily involved in IP litigation of several blockbuster drugs. AnnSofie is specialized in IPstrategic matters with a heavy focus on the US legislation particularly IP in the interface between patent law and regulatory law. She is also part of a number of management teams within the Karolinska Development portfolio companies. since 2012.
Age 53
Tenure 12 years
Phone46 8 52 48 60 70
Webhttps://www.karolinskadevelopment.com

Karolinska Development Management Efficiency

The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1059) %, meaning that it generated substantial loss on money invested by shareholders. Karolinska Development's management efficiency ratios could be used to measure how well Karolinska Development manages its routine affairs as well as how well it operates its assets and liabilities.
Karolinska Development AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. Karolinska Development AB was founded in 2003 and is headquartered in Stockholm, Sweden. Karolinska Development operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 7 people. Karolinska Development AB (KDEV) is traded on Stockholm Exchange in Sweden and employs 7 people.

Management Performance

Karolinska Development Leadership Team

Elected by the shareholders, the Karolinska Development's board of directors comprises two types of representatives: Karolinska Development inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Karolinska. The board's role is to monitor Karolinska Development's management team and ensure that shareholders' interests are well served. Karolinska Development's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Karolinska Development's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hans Wigzell, Independent Chairman of the Board
Elisabet Gimbringer, Controller
Carl Sundberg, Director
Magnus Persson, Director
Jim Heusden, CEO
Maria Ferm, Executive Assistant
HansOlov Olsson, Director
Theresa Tse, Director
Viktor Drvota, Chief Investment Officer
Esther Simo, Analyst
John MD, Chief Partner
Eva Montgomerie, Head of Accounting
Michael Owens, Controller
Yan Cheng, President Asia
Ulf Richenberg, General Counsel
Niclas Adler, Director
Tse Ping, Director
Christian Tange, CFO
Daniel Bolanowski, Business Analyst
Per Aniansson, Investment Director
Johan Dighed, Chief CEO
Terje Kalland, Chief Scientific Officer
Linda Spahiu, Investment Mang
Vladimir Artamonov, Independent Director
Felicia Rittemar, Analyst
AnnSofie Sternas, Vice President IPR
Anders Harfstrand, Director
Bo Hansen, Chairman of the Board
Viktor MD, Chief Officer
Fredrik Jarrsten, CFO
Khalid Islam, Director
Gunilla Ekstrom, Vice President - Operations
Hans Toll, Chief Officer
Henrijette Richter, Director

Karolinska Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Karolinska Development a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Karolinska Development in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Karolinska Development's short interest history, or implied volatility extrapolated from Karolinska Development options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Karolinska Development AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Karolinska Stock analysis

When running Karolinska Development's price analysis, check to measure Karolinska Development's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karolinska Development is operating at the current time. Most of Karolinska Development's value examination focuses on studying past and present price action to predict the probability of Karolinska Development's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karolinska Development's price. Additionally, you may evaluate how the addition of Karolinska Development to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Please note, there is a significant difference between Karolinska Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Karolinska Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Karolinska Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.